BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36951619)

  • 1. LncRNA MBNL1-AS1 knockdown increases the sensitivity of hepatocellular carcinoma to tripterine by regulating miR-708-5p-mediated glycolysis.
    Zhang H; Zhao L; Ren P; Sun X
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-18. PubMed ID: 36951619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis.
    Su J; Chen D; Ruan Y; Tian Y; Lv K; Zhou X; Ying D; Lu Y
    Bioengineered; 2022 Mar; 13(3):6978-6995. PubMed ID: 35311623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SLC9A3-AS1 knockdown increases the sensitivity of liver cancer cell to triptolide by regulating miR-449b-5p-mediated glycolysis.
    Zhao L; Zhang H; Ren P; Sun X
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-17. PubMed ID: 36946780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripterine Restrains the Aggressiveness of Hepatocellular Carcinoma Cell via Regulating miRNA-532-5p/CXCL2 Axis.
    Jiang ZT; Han Y; Liu XY; Lv LY; Pan JH; Liu CD
    Onco Targets Ther; 2020; 13():2973-2985. PubMed ID: 32308429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.
    Shen X; Li Y; He F; Kong J
    Cancer Manag Res; 2020; 12():6807-6819. PubMed ID: 32801906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
    Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
    Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma.
    Li X; Li Y; Bai S; Zhang J; Liu Z; Yang J
    Cancer Manag Res; 2021; 13():427-437. PubMed ID: 33488124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway.
    Xu L; Zhu S; Tang A; Liu W
    Inflamm Res; 2021 Feb; 70(2):217-227. PubMed ID: 33454803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
    Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
    Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
    Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
    Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SH3BP5-AS1 promotes hepatocellular carcinoma progression by sponging miR-6838-5p and activation of PTPN4.
    Zhao X; Zhu X; Xiao C; Hu Z
    Aging (Albany NY); 2024 May; 16():. PubMed ID: 38761175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA ZEB2-AS1 Promotes Hepatocellular Carcinoma Progression by Regulating The
    Wu SM; Chen J; Liang Y; Luo Q; Tong YY; Xie L
    Cell J; 2022 Jun; 24(6):285-293. PubMed ID: 35892230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.